MARK SACHER: Open Payments
NPI 1679567812 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$751 in 37 payments from 10 companies in 2025. Trend: 2023 $821 · 2024 $818 · 2025 $751
Food & beverage: $751
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 14 | $258 |
| ABBVIE INC. | 7 | $175 |
| PFIZER INC. | 8 | $145 |
| PROTEGA PHARMACEUTIALS INC | 2 | $34 |
| Averitas Pharma Inc. | 1 | $31 |
| Braeburn Inc. | 1 | $28 |
| BIOTRONIK NRO, Inc. | 1 | $23 |
| Indivior Inc. | 1 | $21 |
| Orexo US, Inc. | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: Belbuca, NURTEC ODT, UBRELVY, QULIPTA, ROXYBOND, QUTENZA, BRIXADI, Prospera.
Industry payments across FL — which companies pay providers there.
